Ignite Creation Date:
2025-12-25 @ 4:17 AM
Ignite Modification Date:
2025-12-26 @ 3:17 AM
Study NCT ID:
NCT05156320
Status:
COMPLETED
Last Update Posted:
2025-03-07
First Post:
2021-12-01
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Efficacy and Safety of Apitegromab in Patients With Later-Onset Spinal Muscular Atrophy Treated With Nusinersen or Risdiplam
Sponsor:
Scholar Rock, Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2022-04-14
Start Date Type:
ACTUAL
Primary Completion Date:
2024-12-18
Primary Completion Date Type:
ACTUAL
Completion Date:
2024-12-18
Completion Date Type:
ACTUAL
First Submit Date:
2021-12-01
First Submit QC Date:
None
Study First Post Date:
2021-12-14
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
2025-12-16
Disp First Post Date Type:
None
Last Update Submit Date:
2025-03-04
Last Update Post Date:
2025-03-07
Last Update Post Date Type:
ACTUAL